In 2009, The Dean of Penny Stocks taught the investment world about INVO Bioscience (OTC: IVOB.OB), a biotechnology company quickly becoming known for bringing their low-cost infertility treatment device to countries all around the world.
IVOB is currently marketing their INVOcell device on several continents, with distribution and sales in more than thirty countries.
IVOBs INVOcell device has received CE Mark approval and the company is pursuing U.S. FDA 510K clearance. With 150 million infertile couples in the world looking for an affordable, effective and more natural IVF treatment, The Dean thinks IVOB could continue to make all of his students Pregnant Profits.
so Dean, is this still a winner?? trading at .01 now ??????
letsgosteelers68 2 months ago